In epidemiologic studies of two binary exposure factors, much attention has been given to the concept of synergism of the factors. The leading dictionary of epidemiology offers two definitions of synergism, one of which this author labels statistical and the other biologic. The epidemiologic literature has been largely concerned with statistical synergism, which is typically measured using additive or multiplicative interaction. This paper focuses on biologic synergism, on the related concept of biologic parallelism, and on the question of how much information can be gleaned about population amounts of biologic synergism and parallelisminformation which is of vital interest to epidemiologists. A fundamental identity equates the difference between the amounts of biologic synergism and parallelism to the additive interaction. Two biologic models, the multistage model and the no-hrt or immunity model, enhance the interpretation of multiplicative interaction as a measure of statistical synergism, but it is pointed out here that, unfortunately, both models incorporate the strong assumption that there is no parallelism. A third model, the single-hit or vulnerability model, makes the even stronger assumption that there is no biologic synergism and consequently that the additive interaction is equal to minus the amount of parallelism A consequence of this fact is that a link which has been perceived in the literature to exist between the single-hit model and the additive interaction is false. Am J Epidemiol 1997; 145:661-8. 
tical interaction or by multiplicative statistical interaction. These publications may therefore be considered to relate to the dictionary's first definition because, when "effect" is interpreted at the population level as risk difference (attributable risk) or risk ratio (relative risk), synergism is equated to additive or multiplicative interaction. These notions of "statistical synergism" will be revisited in this paper, but the principal focus will be on "biologic synergism" as given in the dictionary's second definition.
According to this definition, which has been discussed by Miettinen (2), Rothman (3, 4) , Koopman (5), Hamilton (6), Greenland and Poole (7), and Darroch and Borkent (8) , synergism of two factors A and B is a combination of biologic properties possessed by a single individual in relation to some disease D. Three of the properties are those of getting D if exposed to both A and B and, other things being equal, of not getting D if exposed to either A or B alone. There is also the implied fourth property of not getting D if exposed to neither of the factors, provided that we make the assumption, a very reasonable one in most cases of practical interest, that the two factors are "causal." For a given disease D (lung cancer, for example), a risk factor is causal (smoking or asbestos exposure, for example) if an individual who does not 662 Darroch or would not get D in its presence would, other things being equal, also not get D in its absence. For an individual having the above four properties, we shall say that the action of the two risk factors exhibits biologic synergisra. If either factor is "preventive" (rural living, for example) instead of causal, it can be replaced by its causal opposite, whose absence/presence corresponds to the original factor's presence/ absence. Little will be said here about factors which are "directionless," that is, neither causal nor preventive (being male, for example).
The qualification "other things being equal" is important in the above definitions and can be given substance using Rothman's (3) notion of "sufficient cause." The sufficient cause of D, for a given individual, is the minimal set of conditions and events that produced D-minimal in the sense that none of the conditions and events were superfluous. As noted by Koopman (5) , the component causes of a sufficient cause for a given individual comprise both attributes of the individual and attributes of the individual's environment. Koopman suggested that events occurring along a pathogenic pathway might also be considered component causes, but this author prefers to think of them as effects of the sufficient cause. As Rotnman pointed out (4, p. 16), the sufficient cause paradigm permits us to speak deterministically about the influence of a factor on an individual, all of the chance influences in the individual's environment having been absorbed into the constellation of component causes, most of which are hidden from us.
Biologic synergism, called "epidemiologic interaction" by Rotnman (4, p. 313), is present in an individual whose sufficient cause contains both A and B as component causes; if A or B or both A and B are removed from the individual's environment, all of the other component causes remaining the same, D is not incurred. If an individual exposed to A and B does get D, we of course cannot know whether A and B acted synergistically. The most that we can hope to know is the population fraction of such individuals, that is, individuals whose sufficient cause contained A and B. One of the contributions of this paper is the delineation of the extent to which this fraction, the proportional size of die "synergistic class," can be measured.
Two risk factors A and B generate four subpopulations according to whether each factor is absent or present. A given individual necessarily belongs to only one of these subpopulations, so that, of the four properties constituting biologic synergism, only one is observable, as mentioned above. The other three properties, concealed widiin the biology of the individual, depend upon our imagining what would have happened regarding D had the individual belonged to each of the other three subpopulations. For simplicity, we shall focus our attention on the individuals in one of the four subpopulations, and we will choose the subpopulation exposed to both factors; this group will be referred to as "the population" in the ensuing discussion. Within this population, the class of individuals who get D but would not have done so under any of the three milder exposure conditions is the class evincing biologic synergism.
OTHER CLASSES
The synergistic class is just one of several classes. If both factors are directionless, there are 16 classes in total, because each individual either would or would not get D under each of the four exposure conditions. Greenland and Poole (7) listed and named all 16 classes and put them into categories according to invariance considerations which arise when the factor levels, absence and presence, are recoded as presence and absence. Earlier, Miettinen (2) , in a discussion of causal and preventive factors, synergism, antagonism, independence, and interdependence, had listed and named most of the 16 classes. Hamilton (6) observed that when assuming as we do here that both factors are causal, the number of classes is reduced to six. In seeking to measure the sizes of these classes, he complicated the task by trying to distinguish and measure separately "real" and "spurious" synergistic action. Darroch and Borkent (8) commented on this distinction and, more importantly, provided a mathematical discussion of the six classes. The proofs of results given here either were presented in that paper (8) or can be constructed within its framework.
THE SIX CLASSES AND THEIR SIZES
As stated above, when both factors are causal, there are six classes of individuals in the population (that is, the subpopulation exposed to both A and B). Two of these classes are of only minor interest. These are the "all" class of individuals who would get D under all four exposure conditions, and the "none" class who would get D under none of the conditions.
The remaining four classes are the ones of real interest. Besides the synergistic class, there is the "A-only" class of individuals who get D if and only if exposed to A, regardless of the presence or absence of B; for each of these individuals, A, but not B, is a component cause of his or her sufficient cause. Likewise, there is the 5-only class. Finally, there is the class containing individuals for whom the risk factors act "in parallel." These individuals would get D if they were exposed to just one of A and B, but would not if they were exposed to neither A nor B; since they are in Biologic Synergism and Parallelism fact exposed to both A and B, they do get D because of the assumption that the factors are causal. Parallelism does not fit naturally into the sufficient cause paradigm, but it can be accommodated within a stretched paradigm by imagining that there is one component of the sufficient cause that can take any one of the three alternative values A, B, and AB. The four classessynergistic, A-only, fi-only, and parallel-thus contain individuals whose sufficient causes include, as components, both A and B in the first case, A in the second, B in the third, and "A or B" in the fourth.
Nothing can be inferred about the sizes of the six classes without assuming that the proportions of individuals in the subpopulation exposed to both factors who would have gotten D under each of the three milder exposure conditions are equal to the actual proportions in the subpopulations so exposed. This "comparability assumption" will be made in this paper.
Let the risks (proportions of individuals getting D) for the four subpopulations exposed to neither A nor B, to A alone, to B alone, and to both A and B be denoted R, R(A), R(B), and R(AB), respectively. The proportional sizes of the six classes sum to 1 and therefore constitute five unknown quantities-one more, unfortunately, than the number of the known quantities R, R(A), R(B), and R(AB). Now the proportional sizes of the "all" class and the "none" class are easily seen to be R and 1 -R(AB), and it is the other four class sizes, denoted |synergism|, |parallelism|, |A-only|, and \B-only|, which cannot in general be fully determined. The first thing to note about them, given the causal factor assumption and the comparability assumption, is that their sum is the risk difference R(AB)-R. This is because the four classes together contain all of the individuals who do get D but would not have done so under the null exposure.
Certain pairs of the four sizes sum to other risk differences, as indicated in table 1. For example, the sum of the sizes |synergism| and |A-only| is the risk difference R(AB)-R(B), while the sum of the sizes |A-only| and |parallelism| is the risk difference R(A)-R. 
R(AB)-R
The significance of this equation is that it provides a new interpretation of additive interaction as the difference between the population amounts of biologic synergism and biologic parallelism. It contrasts with the traditional interpretation of additive interaction as one of the measures of statistical synergism, measuring the excess of the combined effect over the sum of the solitary effects. The equation shows that, if the additive interaction is positive, so is |synergism|. It also shows that biologic parallelism, in contributing negatively to additive interaction, can be thought of as an opposite of biologic synergism. It has been traditional to think of the negative influence on the additive interaction as arising from antagonism. However, biologic antagonism, described in the dictionary's second definition as being present in individuals "who will get the disease when exposed to one of the factors alone, but not when exposed to both," has been ruled out of existence in this paper by our assumption that the risk factors are causal. Without this assumption there would be several classes that could be given the antagonism label, and their sizes would indeed contribute negatively to the additive interaction. The formula for their contributions is implicit in the paper by Greenland and Poole (7), where the additive interaction is displayed as a function of the sizes of the 16 classes which exist when the factors are directionless. Rothman (4, p. 314) omitted the existence of parallelism and was led to equate |synergism| with the additive interaction, whereas |synergism| is, in fact, greater than or equal to it. Koopman had earlier stated that "The interaction contrast of disease rates ... is shown always to be zero or slightly negative when the assumptions of no interaction in the sufficient component discrete causes model hold" (5, p. 716). In the terminology of this paper, Koopman said that the additive interaction is shown to be zero or slightly negative when |synergism| is zero. This statement is incorrect in its use of the adjective "slightly" because, when |synergism| is zero, the additive interaction is equal to -|parallelism|, and no restriction exists on the amount of parallelism that can be present. Table 1 encapsulates all of the information that can be gleaned about the four unknown sizes from the four risks R, R(A), R(B), and R(AB) and only provides three equations for the four unknowns. It is impossible to find a fourth equation. This is because it is impossible (8) to unearth any information about the population proportion of individuals who would get D if exposed to A alone and also would get D if exposed to B alone, and it means that, in general, it is impossible to calculate the four sizes exactly from the four risks.
However, the four class sizes are fully determined by the four risks in some extreme circumstances, one kind of which will be mentioned below in comments on biologic models for disease causation. The other kind of extreme circumstance occurs when two of the risks are equal. If, for example, R(B)=R, then we immediately know that both |fi-only| and |parallelism| are zero, that |synergism| is R(AB)-R(A), and that |A-only| is R(A)-R. In the even more extreme case of two equalities among the four risks, only one of the four class sizes is nonzero.
If R(A) = R(B) = R, the only nonzero size is |synergism|; if R(AB) = R(A) = R(B), it is |parallelism|; if R(AB) = R(A) and R(B) = R, it is |A-onlv|; and if R(AB) = R(B) and R(A) = R, it is |B-only|.
Before specifying what can be determined about the class sizes in the general case, let us first consider an example. Hertz-Picciotto et al. (9) , in a paper on the synergism of arsenic and smoking in the causation of lung cancer, reported the results of several studies, among them a study of retired smelter workers from Tacoma, Washington. The factors are A = smoking and B = arsenic exposure, while D = lung cancer. The value of the risk R in the unexposed subpopulation was not reported in the article (9), but, relative to it, the other risks were R(A) = 7. The size table is shown in table 2 , and we see that |5-only|, the amount of arsenic-only action, must lie between 0 and 4.1/?, from which it follows that |syn-ergism| must be confined to the range from 9.4/? to 13.5/?. Thus, 45 percent (9.4/20.7) to 65 percent (13.5/ 20.7) of cases among workers exposed to both smoking and arsenic were attributable to the synergistic action of these two factors. This is useful information with which we must be satisfied in the face of the impossibility of knowing |synergism| exactly. Furthermore, |parallelism| is between 0 and 4. 
STATISTICAL SYNERGISM
The Dictionary of Epidemiology's (1) first definition of synergism is not one definition but an infinite collection of definitions which result from the infinity of ways of defining the "effect" of a factor. One member of this infinite collection is biologic synergism, obtained by defining effect at the individual level as the all-or-nothing property of getting or not getting D; in order to exceed the sum of the solitary effects, the combined effect of A and B must be D and the solitary effects of A and of B must be not-D, and this exactly describes biologic synergism.
It is more usual to define effect at the population level and so produce a definition of "statistical synergism." When effect is risk difference, the combined effect of A and B is R(AB)-R, and the excess of this over the sum of the solitary effects of A and of B is
[R(AB) -R] -[R(A) -R\ -[R(B) -R] = R(AB) -R(A) -R(B) + R.
Statistical synergism is thus equated to the additive interaction; and if, in a given application, the interaction turns out to be negative, so that the combined effect is less than the sum of the solitary effects, it has been customary to then say that there is (statistical) antagonism.
When effect is measured by risk ratio or, to precisely fit the definition 1 reference to the sum of effects, by log(risk ratio), the excess of the combined effect over the sum of the solitary effects is equal to
\og[R(AB)/R] -\og[R(A)/R] -\og[R{B)/R] = log[R(AB)RJR(A)R(B)l
which is the logarithm of the multiplicative interaction of A and B, so that statistical synergism and antagonism are measured by multiplicative interaction.
Breslow and Storer (10) considered a "power-law" family of definitions of effect, giving rise to a powerlaw family of definitions of statistical synergism, two members of which are additive interaction and multiplicative interaction.
The ambiguity in definition 1, which is manifested in the infinite choice of definitions of statistical synergism, greatly weakens the usefulness of any one of these definitions. Many authors, too numerous to list here, have confined their attention to a choice between additive and multiplicative interaction. Thompson (11) , in his review of the literature, describes some of the difficulties presented by this choice. One difficulty lies in the notorious fact that statistical synergism according to the additive definition can coexist with statistical antagonism according to the multiplicative definition. This phenomenon occurs in the smokingarsenic-lung cancer data discussed above: the additive interaction is 9AR, while the multiplicative interaction is 0.564.
By contrast with the ambiguous definition 1, definition 2 provides us with the unambiguous concept that we have called biologic synergism. Parallelism is also unambiguously defined, and the interpretation of additive interaction as the amount by which biologic synergism exceeds parallelism confers a special status on additive interaction, setting it apart from the other members of the infinite family of definitions of statistical synergism.
BIOLOGIC MODELS FOR DISEASE CAUSATION
A number of biologic models for disease causation have been advanced in the literature. Two of them, the multistage model and the no-hit model or immunity model, are linked to multiplicative interaction, while the single-hit or vulnerability model has been linked (falsely, as we shall explain) to additive interaction. Siemiatycki and Thomas (12) and Thompson (11) reviewed these models and emphasized, with many examples, what might be called the "fallacy of the inverse implication." For example, when combined with an independence property, the multistage model implies no multiplicative interaction. However, we cannot conclude from the absence of multiplicative interaction that the multistage model and the independence property are true, tempting as it is to do draw these conclusions; there are other biologic models which also imply no multiplicative interaction, and any one of them, or none of them, could be true.
The usual formulations of these biologic models are probabilistic: the individual makes stochastic transitions from stage to stage in the case of the multistage model, receives random "health hits" in the no-hit model, and receives random "disease hits" in the single-hit model. Here we provide formulations in a deterministic framework which accords with the sufficient-cause paradigm, and then we examine the models in the light of the six-class structure.
The vulnerability model
The single-hit model was named by Walter and Holford (13) (8) formulated it deterministically as the "vulnerability model," as follows. An individual gets D if and only if he or she possesses at least one type of vulnerability to D. There are three kinds of vulnerability. One manifests itself when A is present and one when B is present, and the other is a blanket vulnerability which manifests itself universally. An individual having no vulnerabilities is in the "none" class; someone having only the first type of vulnerability is in the A-only class; someone having only the first two types of vulnerability is in the parallel class; and someone having the third type of vulnerability is in the "all" class. The vulnerability model implies that the synergistic class is empty and that the additive interaction therefore equals -|paral-lelism| and is less than or equal to zero. It follows that, when the additive interaction is positive, the vulnerability model cannot hold.
We have interpreted statistical synergism in accordance with Last's first definition (1) as a positive difference between the combined effects of A and B and the sum of their solitary effects, and statistical antagonism as a negative difference. In the literature on the vulnerability model, alias the single-hit model, there is an alternative concept of statistical synergism and antagonism as positive and negative dependence in the distribution of the A and B vulnerabilities. Moreover, there is a perception in this literature that this dependence can be measured by the additive interaction. It is apparent from the previous paragraph that this perception must be incorrect, and we need to examine the false argument which led to it. What is true is that positive or negative statistical dependence in the distribution of the A and B vulnerabilities in that part of the population not having the blanket vulnerability is equivalent to the positiveness or negativeness of the quantity -
R(AB)]\_l -R] -
It is the next step in the argument that is the false one. It reasons that, if the four risks are small, which they invariably are, then their products can be neglected and the positiveness or negativeness of the above quantity is the same as the negativeness or positiveness (note the sign reversal, which is sometimes missed) of the additive interaction
R(AB) -R(A) -R(B) + R.
While this reasoning would be valid in general, it is not so under model conditions which demand that the additive interaction is negative.
The immunity model
The "no-hit model," proposed by Walter and Holford (13) , supposes that individuals who become diseased are those who receive no random hit, while individuals who receive at least one hit remain healthy. Darroch and Borkent (8) reformulated it as the "immunity model." It is the mirror image of the vulnerability model. It is assumed that an individual does not get D if and only if he or she possesses at least one type of immunity to D, there being three kinds of immunity. One manifests itself when A is absent and one when B is absent, and the other is a blanket immunity which manifests itself universally. (Thompson (11) describes this model in terms of two preventive factors whose presence corresponds to the absence of our causal factors A and B.) Thus, an individual with no immunity is in the "all" class, a person with just the first type of immunity is in the A-only class, one with just the first two types of immunity is in the synergistic class, and one with the third type of immunity is in the "none" class. The immunity model implies that there is no parallelism and therefore that the additive interaction is positive. A negative additive interaction immediately invalidates the immunity model.
The immunity model is linked to multiplicative interaction in the following way. There is positive or negative multiplicative interaction depending on whether the distribution of the A and B immunities is positively or negatively dependent in that part of the population comprising the individuals who do not have the blanket immunity and who therefore do get D as they are exposed to both A and B.
The multistage model
The multistage model of carcinogenesis was proposed by Armitage and Doll (20) and developed by Moolgavkar (21) , among others. In the two-stage version, it is assumed that D is the second stage of a disease which is only reached via a first stage D', and that the factors A and B each influence only one stage. The model can be given a deterministic formulation appropriate to the sufficient cause paradigm as follows. Let D" denote that property of the biology of an individual which ensures that, if the individual gets D', he or she will also get D. The statistical interest shown in the literature towards the two-stage model is centered on a link between it and multiplicative interaction. Let a prime denote the property of getting D' when A is absent and a double prime the property of having D" when B is absent. Then the multiplicative interaction is positive or negative depending on whether the distribution of prime and double prime is positively dependent or negatively dependent in that part of the population which does get D=(D', IT). Thus, within the framework of the two-stage model, statistical synergism, as measured by multiplicative interaction, can be interpreted as meaning that prime and double prime occur together in the same individual more often than independently, and statistical antagonism as meaning that they occur less often. If prime and double prime are distributed independently, then there is no multiplicative interaction and A and B may be said to "act multiplicatively." It is important to note that this multiplicative action is a population property and says nothing about any single individual; with regard to prime and double prime, an individual simply has none, one, or both.
These results for a two-stage disease immediately extend to cover a multistage disease, some stages of which are insensitive to A while the others are insensitive to B.
DISCUSSION
Much attention been directed in the literature towards determining whether a no-interaction constraint can be placed on the four risks R, R(A), R(,B), and R(AB), thus effectively reducing the four parameters to three. The emphasis in this paper has been in the opposite direction of not seeking to constrain the four parameters but, instead, saying something about the five underlying parameters which determine the proportional sizes of the six classes into which a population exposed to two causal factors can be partitioned. The sizes of the "none" and "all" classes are fully determined by the four risks, but the sizes of the other four classes-the synergistic, parallel, A-only, and S-only classes-are determined only to a partial degree, which varies from context to context. The incompleteness of our knowledge of the four sizes does not imply any shortcoming in the theory, but exists simply because Nature only partially reveals the sizes to us. In addition to this fundamental uncertainty about |synergism|, |parallelism|, |A-only|, and |B-only{, there is the usual inferential uncertainty which arises from estimating the population risks R(AB), R(A), R(B), and R from sample information. We have, for simplicity, ignored inferential uncertainty in this paper and spoken of the four risks as if they were known, unlike Walker (22) , who did provide some formulae for estimation variances.
The notions of "independent action" and "interdependent action" are featured in the literature, but have not been required in this paper. It would in fact be difficult to know which adjective, independent or interdependent, to apply to some of the six types of action represented by the six classes.
Implicit to this paper is the belief that epidemiologists would like to know the sizes of the six classes. If the synergistic class were found to be dominant, the public health concern would be a reduction of exposure to either A or B. This raises the issue of which reduction should be given priority, as noted recently by Saracci and Boffetta (23) ; information on the sizes of the A-only and fi-only classes, particularly the fact, not mentioned previously, that
|A-only| -|fl-only| = R(A) -R(B),
should help to resolve this issue. If it happened that parallelism were dominant, the public health concern would be to reduce exposure to both A and B.
In seeking to understand why there is biologic synergism, the epidemiologist postulates pathogenic pathways to D which require exposure to both A and B. In the example from Hertz-Picciotto et al. (9) , we found that 45-65 percent of the cases exhibited biologic synergism. These authors suggested several possible pathways to lung cancer which require exposure to both smoking and arsenic. One of these suggestions was that "cigarette smoking impedes tracheobronchial clearance, which could prolong the exposure of bron-chial epithelium to arsenic-containing participates and magnify the dose to the target tissue"; another that "arsenic deposited in the lung may enhance proliferation of cells already subjected to the initiating and promoting activities of other carcinogens in mainstream tobacco smoke" (9, p. 29).
The single-hit, no-hit, and multistage models were designed to assist the study of how two exposure factors affect the incidence of a disease. Their status in this role has been reduced by the increased awareness that, while it is true that these biologic models imply certain interaction properties, it is false to inversely conclude that the biologic model is valid when the interaction property holds. The status of these models is reduced further by the facts reported here-namely, that the first model incorporates the restriction that there is no synergism and the second and third models the restriction that there is no parallelism. While it is impossible to infer the truth, in a given study, of any one of these models, with or without an assumption of statistical independence, falsity can certainly be inferred if the additive interaction has the wrong sign. The single-hit model must be false if the additive interaction is positive, and the other two must be false if the additive interaction is negative. Finally, an investigator who is bold enough to assume a priori the validity of any of these models knows that either |synergism| or |parallelism| is zero, and hence knows the sizes of the other five classes.
